2,3-dichloropyrrole | 39205-33-9

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 芳基卤化物
• 英文名称: 2,3-dichloropyrrole
• 英文别名: Dichloropyrrole；2,3-dichloro-1H-pyrrole
• CAS: 39205-33-9
• 化学式: C₄H₃Cl₂N
• mdl: MFCD18449504
• 分子量: 135.981
• InChiKey: NXVWESYBAJSRQF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  15.8
• 氢给体数：
  1
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  三异丙基氯硅烷 、 2,3-dichloropyrrole 在 sodium hydride 作用下， 以 四氢呋喃 、 mineral oil 为溶剂， 以436 mg的产率得到2,3-dichloro-1-(triisopropylsilyl)pyrrole
  参考文献：
  名称：

  Revised Structure and Synthesis of Celastramycin A, A Potent Innate Immune Suppressor

  摘要：

  After searching for natural substances that regulate innate immunity using the ex vivo Drosophila culture system, a benzoyl pyrrole-type compound, celastramycin A, was identified and isolated as a potent suppressor. By synthesizing the previously reported structure 1 and another benzoyl pyrrole-type compound 2 reported in a Japanese patent, the correct structure of celastramycin A was confirmed to be 2. Compound 2 suppressed the production of IL-8 (IC50 0.06 mu g/mL) in human umbilical vein endothelial cells (HUVECs).

  DOI：

  10.1021/ol9002306
• 作为产物：
  描述：

  4,5-二氯-1H-吡咯-2-羧酸 以 C.I.酸性橙108 为溶剂， 反应 4.0h， 生成 2,3-dichloropyrrole
  参考文献：
  名称：

  Revised Structure and Synthesis of Celastramycin A, A Potent Innate Immune Suppressor

  摘要：

  After searching for natural substances that regulate innate immunity using the ex vivo Drosophila culture system, a benzoyl pyrrole-type compound, celastramycin A, was identified and isolated as a potent suppressor. By synthesizing the previously reported structure 1 and another benzoyl pyrrole-type compound 2 reported in a Japanese patent, the correct structure of celastramycin A was confirmed to be 2. Compound 2 suppressed the production of IL-8 (IC50 0.06 mu g/mL) in human umbilical vein endothelial cells (HUVECs).

  DOI：

  10.1021/ol9002306

文献信息

• [EN] MCL-1 MODULATING COMPOSITIONS<br/>[FR] COMPOSITIONS DE MODULATION DE MCL-1
  申请人：PENN STATE RES FOUND

  公开号：WO2013112878A1

  公开（公告）日：2013-08-01

  The present invention relates to marinopyrrole A derivatives and pyoluteorin derivatives and methods of treatment of disorders associated with misregulation of Mcl-l, e.g., leukemia, lymphoma, multiple myeloma, melanoma, or pancreatic cancer. We describe exemplary compounds, which may be contained in pharmaceutical compositions, and their use as therapeutic agents either alone or in combination with other anti-cancer treatments, e.g., anti-Bcl- 2 agents.

  本发明涉及海洋吡咯酮A衍生物和吡洛特霉素衍生物，以及治疗与Mcl-l误调节相关的疾病的方法，例如白血病、淋巴瘤、多发性骨髓瘤、黑色素瘤或胰腺癌。我们描述了一些示范性化合物，这些化合物可以包含在药物组合物中，并且它们可作为治疗剂单独使用或与其他抗癌治疗方法结合使用，例如抗Bcl-2剂。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
  申请人：GLAXOSMITHKLINE LLC

  公开号：WO2010059658A1

  公开（公告）日：2010-05-27

  The invention is directed to 6-(4-pyιϊmidinyl)-1 H-indazole derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R1 - R4 are defined herein. The compounds of the invention are inhibitors of PDK1 and can be useful in the treatment of immune and metabolic diseases and disorders characterized by constitutively activated ACG kinases such as cancer and more specifically cancers of the breast, colon, and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting PDK1 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  这项发明涉及6-(4-吡咯嗪基)-1 H-吲唑衍生物。具体而言，该发明涉及符合式(I)的化合物，其中R1-R4在此处被定义。该发明的化合物是PDK1的抑制剂，可用于治疗由于恒定激活的ACG激酶所特征化的免疫和代谢性疾病和紊乱，如癌症，更具体地说是乳腺癌、结肠癌和肺癌。因此，该发明进一步涉及包括该发明化合物的药物组合物。该发明还进一步涉及使用该发明化合物或包括该发明化合物的药物组合物来抑制PDK1活性和治疗相关疾病的方法。
• CHEMICAL COMPOUNDS
  申请人：Axten Jeffrey Michael

  公开号：US20110275611A1

  公开（公告）日：2011-11-10

  The invention is directed to 6-(4-pyrimidinyl)-1H-indazole derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R 1 -R 4 are defined herein. The compounds of the invention axe inhibitors of PDK1 and can be useful in the treatment of immune and metabolic diseases and disorders characterized by constitutively activated ACG kinases such as cancer and more specifically cancers of the breast, colon, and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting PDK1 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention

  本发明涉及6-(4-嘧啶基)-1H-吲唑衍生物。具体而言，本发明涉及公式（I）中R1-R4所定义的化合物。本发明的化合物是PDK1的抑制剂，可用于治疗免疫和代谢性疾病和障碍，这些疾病和障碍以恒定激活的ACG激酶为特征，例如乳腺、结肠和肺癌等。因此，本发明还涉及包含本发明化合物的制药组合物。本发明还涉及使用本发明化合物或包含本发明化合物的制药组合物抑制PDK1活性和治疗相关障碍的方法。
• 1,2,4,6-Thiatriazin-1,1-dioxid-ether, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
  申请人：BASF Aktiengesellschaft

  公开号：EP0102542A2

  公开（公告）日：1984-03-14

  Die Erfindung betrifft 1,2,4,6-Thiatriazin-1,1-dioxid-ether der Formel in der R1, R2, R3, Y, Z und n die in der Beschreibung genannten Bedeutungen haben, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuches.

  本发明涉及式 1,2,4,6-噻三嗪-1,1-二氧化物醚。 式中 R1、R2、R3、Y、Z 和 n 的含义，及其制备工艺和在防治植物不良生长方面的用途。
• Verfahren zur elektrochemischen Beschichtung von Kohlenstoff-Fasern
  申请人：BASF Aktiengesellschaft

  公开号：EP0217099A2

  公开（公告）日：1987-04-08

  Verfahren zum Aufbringen einer Schicht aus elektrisch leitfähigen Poly­meren, bei dem man Kohlenstoff-Fasern oder Fäden oder flächige Gebilde aus Kohlenstoff-Fasern oder Fäden mit Sulfonsäuren von Phthalocyaninen oder Porphyrinen beschichtet, die so behandelten Fäden in einer Lösung, die Monomere aus der Klasse der 5-gliedrigen Heterocyclen enthält, als Anode schaltet und die Monomeren anodisch polymerisiert, so daß sich eine leitfähige Schicht auf den Fasern, Fäden oder flächigen Gebilden ausbil­det.

  一种涂覆导电聚合物层的工艺，在这种工艺中，碳纤维或碳丝或碳纤维或碳丝的片状结构涂覆酞菁或卟啉的磺酸，经过这种处理的碳丝在含有五元杂环类单体的溶液中作为阳极切换，单体发生阳极聚合反应，从而在纤维、碳丝或片状结构上形成导电层。